Skip to main content

Research Repository

Advanced Search

Depression, Anxiety, and Stress Among Patients with COVID-19: A Cross-Sectional Study

Moayed, Malihe Sadat; Vahedian-Azimi, Amir; Mirmomeni, Golshan; Rahimi-Bashar, Farshid; Goharimoghadam, Keivan; Pourhoseingholi, Mohamad Amin; Abbasi-Farajzadeh, Mohsen; Hekmat, Mostafa; Sathyapalan, Thozhukat; Guest, Paul C.; Sahebkar, Amirhossein

Authors

Malihe Sadat Moayed

Amir Vahedian-Azimi

Golshan Mirmomeni

Farshid Rahimi-Bashar

Keivan Goharimoghadam

Mohamad Amin Pourhoseingholi

Mohsen Abbasi-Farajzadeh

Mostafa Hekmat

Paul C. Guest

Amirhossein Sahebkar



Contributors

Paul C. Guest
Editor

Abstract

© 2021, The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG. Aim: Patients with confirmed COVID-19 infection can develop several psychological consequences. Epidemiological data on mental health and psychological disorder inpatients infected with COVID-19 pneumonia are not available in Iranian patients. The purpose of this study was to evaluate the anxiety, stress, and depression of patients with COVID-19. Material and Methods: This cross-sectional survey was conducted in 2020. All confirmed patients with COVID-19 were included in the study by census sampling. Assessment of depression, stress, and anxiety was performed using the DASS-21 questionnaire. All statistical analyses were performed using R version 3.5.1. Results: The questionnaires were completed by 221 patients with COVID-19 infection (204 males, 17 females). The mean age was 45.90 ± 7.73 years. Our results indicated that the mean scores of depression and anxiety were at “extremely severe” levels, while stress levels were “severe.” The prevalence of “extremely severe” symptoms of depression and anxiety was 54.29% and 97.29%, respectively. The prevalence of severe stress was 46.61%. Conclusion: In this study, patients infected with COVID-19 reported severe and extremely severe experience psychological distress. Further studies should focus on the combined use of psychological and molecular biomarker testing to increase accuracy. Overall, the findings demonstrate the necessity of special intervention programs for the confirmed patients with emerging infectious disease COVID-19 to promote mental health needs.

Citation

Moayed, M. S., Vahedian-Azimi, A., Mirmomeni, G., Rahimi-Bashar, F., Goharimoghadam, K., Pourhoseingholi, M. A., Abbasi-Farajzadeh, M., Hekmat, M., Sathyapalan, T., Guest, P. C., & Sahebkar, A. (2021). Depression, Anxiety, and Stress Among Patients with COVID-19: A Cross-Sectional Study. In P. C. Guest (Ed.), Clinical, Biological and Molecular Aspects of COVID-19 (229-236). Springer. https://doi.org/10.1007/978-3-030-59261-5_19

Online Publication Date Mar 4, 2021
Publication Date Mar 4, 2021
Deposit Date Oct 2, 2022
Publicly Available Date Mar 5, 2023
Publisher Springer
Pages 229-236
Series Title Advances in Experimental Medicine and Biology
Series Number 1321
Book Title Clinical, Biological and Molecular Aspects of COVID-19
ISBN 9783030592608
DOI https://doi.org/10.1007/978-3-030-59261-5_19
Keywords COVID-19; Coronavirus; Patient; Depression; Anxiety; Stress; Iran
Public URL https://hull-repository.worktribe.com/output/3742765

Files

Chapter (359 Kb)
PDF

Copyright Statement
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG






You might also like



Downloadable Citations